RecallDepth
Class II Ongoing

Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90.

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
December 31, 2018
Posted
January 23, 2019
Recall Number
D-0370-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,604 bottles
Firm Location
East Windsor, NJ, United States

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Distribution

Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.

Lot / Code Info

Lot # VUSD17008-A, exp. date 07/2019 Lot # VUSD17009-A, exp. date 09/2019

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls